CMG Ingredient Spotlight March 2026: NMN
Welcome to the CMG Ingredient Spotlight for March 2026. This edition focuses on nicotinamide mononucleotide (NMN), a bioactive nucleotide that has attracted considerable attention in recent years for its potential as a therapeutic agent in addressing age-related health conditions. March has also been a productive month for NMN, with several key articles published. In this […]
Article: A Spotlight on Nicotinamide Mononucleotide (NMN)
In March, a journal article on NMN by Dr Brad McEwen PhD was published, titled “A Spotlight on Nicotinamide Mononucleotide (NMN)”. It was published in the peer-reviewed journal Australasian Journal of Natural Medicine. This article discussed the preclinical research of NMN, including enhancing NAD+ biosynthesis, increasing intracellular NAD+ levels, and improving mitochondrial bioenergetics, cellular energy […]
Welcome to 2026
Happy New Year and Welcome to 2026. After the break, CMG has opened its doors to the new year and is in full swing. We are excited for 2026, the year of innovation. Throughout 2025, we saw customers expand existing product ranges, launch exciting new innovations, and secure placements in new retail stores. These achievements […]
CMG Ingredient Spotlight October 2025: CETO3
Welcome to the October issue of the CMG Ingredient Spotlight! This month, we’re excited to feature CETO3®. Ingredient Spotlight: CETO3® By Dr Brad McEwen PhD, MHSc, MPH, BHSc CMG Head of Products and Innovation Fatty fish are renowned for being rich sources of the essential omega-3 fatty acids EPA (20:5 n-3) and DHA (22:6 n-3), […]
CMG Ingredient Spotlight: Discover the Power of UC-II® for Joint Health
This month, we’re excited to feature UC-II®, a cutting-edge joint health ingredient revolutionising the way we think about collagen. Backed by science and driven by innovation, UC-II® offers powerful support for mobility and flexibility, making it a standout solution in the world of joint care. Additionally, we discuss future orders and an upcoming in-person event […]
New Product Development (NPD)
New Product Development (NPD): A Landmark Year for Complementary Medicines 2025 marks a pivotal year for the complementary medicines industry, driven by robust new product development (NPD) and sustained industry growth. Currently, the Australian complementary medicines market is valued at an impressive $6.2 billion annually. Consumer engagement is at an all-time high, with approximately 75% of […]
Dr Brad Presents at the CMA Innovation Day
CMG’s Dr Brad Presents at the CMA Innovation Day Dr Brad’s presentation provided an examination of the profound influence that complementary medicine is having on the future landscape of healthcare and wellness. He emphasised several critical areas of health conditions, such as mental health, musculoskeletal health (e.g. arthritis), and cardiometabolic health. He highlighted various nutrients […]
New Product Development (NPD) for 2025
New Product Development (NPD) for 2025 By Dr Brad McEwen PhD, MHSc, MPH, BHSc CMG Head of Products and Innovation 2024 marked a significant period for the industry, characterised by substantial new product development (NPD) and overall industry growth. At present, the Australian complementary medicines industry is valued at an impressive $6.2 billion annually. There […]
Q&A with Craig Fallshaw CEO
Where do you draw your inspiration from for CMG? When I was working for my Dad, I noticed that there was a bunch of start up brands that just got zero service from big manufacturers, so I decided that would be a good niche for CMG. We try hard to be make our customer service […]
Thank you for a great year 2024
As 2024 draws to a close, we would like to take a moment to thank you for your support throughout 2024. It is appreciated. This year brought many successes and achievements for our customers. We are very excited about 2025, and we are looking forward to the amazing year ahead. 2024 has been an amazing […]